What was Cognetivity Neurosciences’s price range in the past 12 months?
Cognetivity Neurosciences lowest stock price was $0.01 and its highest was $0.27 in the past 12 months.
What is Cognetivity Neurosciences’s market cap?
Currently, no data Available
When is Cognetivity Neurosciences’s upcoming earnings report date?
Cognetivity Neurosciences’s upcoming earnings report date is Jun 05, 2024 which is in 40 days.
How were Cognetivity Neurosciences’s earnings last quarter?
Cognetivity Neurosciences released its earnings results on Dec 30, 2023. The company reported -$0.022 earnings per share for the quarter, missing the consensus estimate of -$0.014 by -$0.007.
Cognetivity Neurosciences does not currently pay dividends.
What is Cognetivity Neurosciences’s EPS estimate?
Cognetivity Neurosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cognetivity Neurosciences have?
Cognetivity Neurosciences has 89,588,610 shares outstanding.
What happened to Cognetivity Neurosciences’s price movement after its last earnings report?
Cognetivity Neurosciences reported an EPS of -$0.022 in its last earnings report, missing expectations of -$0.014. Following the earnings report the stock price went up 9.091%.
Which hedge fund is a major shareholder of Cognetivity Neurosciences?
Currently, no hedge funds are holding shares in CGNSF
Cognetivity Neurosciences Ltd is developing a platform technology comprising of a visual stimulus based diagnostic test and artificial intelligence tools to support the early detection and monitoring of cognitive impairment in neurodegenerative diseases, with initial emphasis on dementia in Alzheimer's disease and mild cognitive impairment, a difficult-to-diagnose, "pre-dementia" condition.
Copying Stefan Quenneville's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -43.18% per trade.